|
Issue |
Title |
|
No 19 (2019) |
Clinical studies of chemotherapy efficacy in combination with androgenic deprivation in patients with oligometastatic hormone-sensitive prostate cancer |
Abstract
PDF (Rus)
|
S. V. Popov |
|
No 19 (2019) |
Possibilities of treatment of patients with castrationrefractory prostate cancer using enzalutamide |
Abstract
PDF (Rus)
|
B. Ya. Alekseyev, K. M. Nyushko, A. D. Kaprin |
|
No 10 (2019) |
Cabazitaxel in the treatment of castration-resistant cancer: hitting the balance of efficacy and safety |
Abstract
PDF (Rus)
|
M. I. Volkova, Ya. V. Gridneva, A. S. Olshanskaya |
|
No 10 (2019) |
Study of the economic efficiency of the combined method of Octreotide-depo + dexamethasone therapy in the treatment of patients with castration-resistant prostate cancer |
Abstract
PDF (Rus)
|
S. V. Mishugin, I. G. Rusakov, I. V. Novikova, A. A. Gritskevich |
|
No 19 (2018) |
Pazopanib in the treatment of advanced renal cell carcinoma |
Abstract
PDF (Rus)
|
M. I. Volkova, A. S. Olshanskaya |
|
No 19 (2018) |
Luteinizing hormone releasing hormone analogues in the treatment of patients with prostate cancer |
Abstract
PDF (Rus)
|
B. Ya. Alexeev, K. M. Nyushko, A. D. Kaprin |
|
No 19 (2018) |
Cytotoxic therapy for prostate cancer |
Abstract
PDF (Rus)
|
I. G. Rusakov, S. V. Mishugin |
|
No 10 (2018) |
Pazopanib as first-line therapy for patients with metastatic kidney cancer |
Abstract
PDF (Rus)
|
B. Ya. Alekseev, I. M. Shevchuk |
|
No 10 (2018) |
Radium-223 for the treatment of patients with castration-resistant prostate cancer with bone metastases |
Abstract
PDF (Rus)
|
A. D. Kaprin, A. A. Kostin, N. V. Vorobyev, S. V. Popov |
|
No 14 (2017) |
РАК ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ ТЕНДЕНЦИИ И ПЕРСПЕКТИВЫ |
Abstract
PDF (Rus)
|
|
|
No 14 (2017) |
EVALUATION OF EFFECT OF PROLONGED ACTION SOMATOSTATIN ANALOGUE – OCREOTIDE-DEPO – ON THE FOLLOWING HORMONAL AND CYTOTOXIC THERAPY IN PATIENTS WITH METASTATIC CASTRATE-RESISTANT PROSTATE CANCER (М-CRPC) |
Abstract
PDF (Rus)
|
S. V. Mishugin, A. A. Gritskevich, A. A. Mordovin, I. G. Rusakov |
|
No 6 (2017) |
EVALUATION OF EFFICACY OF BUSERELIN-DEPO IN PATIENTS WITH LOCALLY ADVANCED AND METHASTATIC PROSTATE CANCER |
Abstract
PDF (Rus)
|
S. V. MISHUGIN, A. A. DROBYAZKO, A. A. MORDOVIN, A. A. GRICKEVICH, I. G. RUSAKOV |
|
No 6 (2017) |
THE PLACE OF ENZALUTAMIDE IN THE SERIAL TREATMENT OF TREATMENT-RESISTANT PROSTATE CANCER |
Abstract
PDF (Rus)
|
A. A. GRITSKEVICH, S. V. MISHUGIN, I. G. RUSAKOV |
|
No 6 (2017) |
POSSIBILITIES FOR OPTICAL DIAGNOSIS OF MUSCULAR-NONINVASIVE BLADDER CANCER |
Abstract
PDF (Rus)
|
A. A. TRUSHIN, E. V. FILONENKO, I. G. RUSAKOV |
|
No 6 (2017) |
POSSIBILITIES OF RADIUM-223 APPLICATION IN THERAPY OF PROSTATE GLAND CANCER |
Abstract
PDF (Rus)
|
A. A. GRITSKEVICH, S. V. MISHUGIN, I. G. RUSAKOV |
|
No 6 (2017) |
POSSIBILITIES OF A COMBINATION OF DOCETAXEL WITH ANDROGEN DEPRIVATION IN INITIAL THERAPY OF HORMONESENSITIVE PROSTATE CANCER |
Abstract
PDF (Rus)
|
A. A. GRITSKEVICH, S. V. MISHUGIN, I. G. RUSAKOV |
|
1 - 16 of 16 Items |
|